Changes in the shbg concentration during danazol treatment

References

• Asch R. H., Fernandez E. D., Siler-Khodr T. M., Bartke A., Pauerstein C. J. Mechanism of induction of luteal phase defects by danazol. Am J Obstet Gynecol 1980; 136: 932
   Google Scholar
• Barbieri R. L., Lee H., Ryan K. J. Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: Correlation with biological activity. Fertil Steril 1979; 31: 185
   Google Scholar
• Barbieri R. L., Ryan K. J. Danazol: endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol 1981; 141: 453
   PubMed Web of Science ®Google Scholar
• Carlström K., Döberl A., Rannevik G. Peripheral androgen levels in danazol-treated premenopausal women. Fertil Steril 1983; 39: 499
   PubMed Web of Science ®Google Scholar
• Carlström K., Döberl A., Gershagen S., Rannevik G. Peripheral levels of dehydroepiandrosterone sul-fate, dehydroepiandrosterone, androstenedione, and testosterone following different doses of danazol. Acta Obstet Gynecol Scand 1984, Suppl 123: 125
   Google Scholar
• Carlström K., Döberl A., Pousette A., Rannevik G., Wilking N. Inhibition of steroid sulfatase activity by danazol. Acta Obstet Gynecol Scand 1984, Suppl 123: 107
   Google Scholar
• Chamness G. C., Asch R. H., Paurstein C. J. Danazol binding and translocation of steroid receptors. Am J Obstet Gynecol 1980; 136: 426
   Google Scholar
• Dmowski W. P., Scholer H. F. L., Mahesh V. B., Greenblatt R. B. Danazol—a synthetic steroid derivative with interesting physiologic properties. Fertil Steril 1971; 22: 9
   PubMed Web of Science ®Google Scholar
• Dmowski W. P. Endocrine properties and clinical application of danazol. Fertil Steril 1979; 31: 237
   PubMed Web of Science ®Google Scholar
• Fernlund P., Gershagen S., Kjellberg M., Rannevik G. Electro-immunoassay of sex hormone binding globulin. Enhanced sensitivity by autoradiography using A-ring125 1–17-β-oestradiol. Scand J Clin Lab Invest 1984; 44: 25
   PubMed Web of Science ®Google Scholar
• Henderson K. M., Tsang B. K. Danazol suppresses luteal function in vitro and in vivo. Fertil Steril 1980; 33: 550
   Google Scholar
• Krey L. C., Robbins R., McEwen B. S. Danazol suppression of luteinizing hormone secretion: A role for danazol—androgen receptor interaction within the brain -pituitary complex. Fertil Steril 1981; 35: 467
   Google Scholar
• Laurell C. B., Rannevik G. A comparison of plasma protein changes induced by danazol, pregnancy, and estrogens. J Clin Endocrinol Metab 1979; 49: 719
   PubMed Web of Science ®Google Scholar
• Lobo R. A., Goebelsmann U. Effect of androgen excess on inappropriate gonadotropin secretion as found in the polycystic ovary syndrome. Am J Obstet Gynecol 1982; 142: 394
   Google Scholar
• Meldrum D. R., Pardridge W. M., Karow W. G., Rivier J., Vale W., Judd H. L. Hormonal effects of danazol and medical oophorectomy in endometriosis. Obstet Gynecol 1983; 62: 480
   Google Scholar
• Menon M., Azhar S., Menon K. M. J. Evidence that danazol inhibits gonadotropin-induced ovarian steroidogenesis at a point distal to gonadotropin-receptor interaction and adenosine 3′,5′ cyclic monophosphate formation. Am J Obstet Gynecol 1980; 136: 524
   PubMedGoogle Scholar
• Moll G. W., Jr, Rosenfield R. L., Helke J. H. Estradiol—testosterone binding interactions and free plasma estradiol under physiological conditions. J Clin Endocrinol Metab 1981; 52: 868
   PubMed Web of Science ®Google Scholar
• Nilsson B., Södergård R., Damber M. G., von Schoultz B. Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity. Fertil Steril 1982; 38: 48
   PubMed Web of Science ®Google Scholar
• Nilsson B., Södergård R., Damber M. G., Damber J. E., von Schoultz B. Free testosterone levels during danazol therapy. Fertil Steril 1983; 39: 505
   PubMed Web of Science ®Google Scholar
• Nilsson L., Dennefors B., Olsson J. H., Hillensjö T., Rannevik G. In vitro effects of danazol on steroidogenesis in developing human follicles. An interim report. Acta Obstet Gynecol Scand 1984, Suppl 123: 99
   Google Scholar
• Pugeat M. M., Dunn J. F., Nisula B. C. Transport of steroid hormones: Interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53: 69
   PubMed Web of Science ®Google Scholar
• Rannevik G., Thorell J. The influence of danazol on the pituitary function and on the ovarian follicular hormone secretion in premenopausal women. Acta Obstet Gynecol Scand 1984, Suppl 123: 89
   Google Scholar
• Schwarz S., Tappeiner G., Hintner H. Hormone binding globulin levels in patients with hereditary angio-oedema during treatment with danazol. Clin Endocrinol 1981; 14: 563
   Google Scholar
• Tamaya T., Furuta N., Motoyama T., Boku S., Ohono Y., Okada H. Mechanism of antiprogestational action of synthetic steroids. Acta Endocrinol 1978; 88: 190
   Google Scholar